13F filing recap · Q3 2016

What did Matrix Asset Advisors buy in Q3 2016?

Reported stock-position changes between this filing and the previous one.

Stock value

$567.00M

Positions

Estimated turnover

15.4%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

JCIJohnson Controls International Plc$11.70Mreported value+251.5K shares TWXTime Warner Inc$663.0Kreported value+8.3K shares AMGNAmgen Inc.$655.0Kreported value+3.9K shares BLKBlackrock, Inc.$595.0Kreported value+1.6K shares UNHUnitedHealth Group Incorporated$574.0Kreported value+4.1K shares VFCV. F. Corporation$288.0Kreported value+5.1K shares ABTAbbott Laboratories$259.0Kreported value+6.1K shares

Increased positions

JPMJPMorgan Chase & Co$24.62Mreported value+22.5K shares+6.5%MSFTMicrosoft Corporation$21.44Mreported value+10.4K shares+2.9%WFCWells Fargo & Company/mn$20.99Mreported value+33.0K shares+7.5%ETNEaton Corporation Plc$20.57Mreported value+24.1K shares

Reduced positions

TELTe Connectivity Plc$14.64Mreported value-3.2K shares-1.4%ZBHZimmer Biomet Holdings, Inc.$13.77Mreported value-9.9K shares-8.6%MSMorgan Stanley$12.74Mreported value-9.7K shares-2.4%SLBSlb Limited/nv$12.16Mreported value-4.1K shares

Exited positions

JCIJohnson Controls International Plc$13.63Mprior reported value-308.0K shares-100.0%HPEHewlett Packard Enterprise Company$5.42Mprior reported value-296.5K shares-100.0%ULUnilever Plc$3.45Mprior reported value-72.0K shares-100.0%SVONSevion Therapeutics, Inc.$4.0Kprior reported value